Good to finally see a step in the right direction. Fingers crossed the changes to inclusion criterea see an actual acceleration without negatively impacting the outcome.
We should get some indications of initial results by the AGM.
Ann: First Patient Dosed in MND Phase 1/2 Trial, page-5
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
-0.015(8.11%) |
Mkt cap ! $67.30M | |||
| Open | High | Low | Value | Volume |
| 18.5¢ | 18.5¢ | 17.0¢ | $122.7K | 701.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 334458 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 10595 | 1 |
View Market Depth
| Last trade - 16.10pm 28/05/2024 (20 minute delay) ? |
|
|||||
|
Last
17.3¢ |
Change
-0.015 ( 4.17 %) |
||||
| Open | High | Low | Volume | ||
| 18.0¢ | 18.0¢ | 17.0¢ | 899611 | ||
| Last updated 15.56pm 28/05/2024 ? | |||||
| PAA (ASX) Chart |